Skip to main content

What the FDA labels say about taking them together

Cannabidiol and digoxin

Cannabidiol's FDA label of May 29, 2026 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name cannabidiol. The cannabidiol label: “Increases in exposure of other orally administered P‑gp substrates may be observed when concomitantly used with EPIDIOLEX.”

Check it at the source: the cannabidiol FDA label on DailyMed (effective May 29, 2026, Jazz Pharmaceuticals, Inc.); the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.).

What does the cannabidiol label say about digoxin?

Cannabidiol label, drug interactions

Increases in exposure of other orally administered P‑gp substrates (e.g., sirolimus, tacrolimus, digoxin) may be observed when concomitantly used with EPIDIOLEX.

Source: FDA drug label (Epidiolex), Jazz Pharmaceuticals, Inc., effective May 29, 2026 (SPL set 8bf27097-4870-43fb-94f0-f3d0871d1eec), via openFDA; the full label on DailyMed

What does the digoxin label say about cannabidiol?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name cannabidiol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cannabidiol generic labelers
26Digoxin generic labelers
CannabidiolDigoxin
Labeled forn/aHeart failure, Atrial fibrillation
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.133 per tablet 125 mcg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?